Loading...
Please wait, while we are loading the content...
Antibody-drug conjugates: beyond current approvals and potential future strategies.
| Content Provider | Europe PMC |
|---|---|
| Author | Menon, Siddharth Parakh, Sagun Scott, Andrew M. Gan, Hui K. |
| Editor | Stathis, Anastasios |
| Copyright Year | 2022 |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC9400743&blobtype=pdf |
| Volume Number | 3 |
| DOI | 10.37349/etat.2022.00082 |
| PubMed Central reference number | PMC9400743 |
| Issue Number | 2 |
| PubMed reference number | 36046842 |
| Journal | Exploration of Targeted Anti-tumor Therapy [Explor Target Antitumor Ther] |
| e-ISSN | 26923114 |
| Language | English |
| Publisher | Open Exploration |
| Publisher Date | 2022-04-28 |
| Access Restriction | Open |
| Rights License | This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. © The Author(s) 2022. |
| Subject Keyword | Antibody-drug conjugates immunotherapy tumour microenvironment |
| Content Type | Text |
| Resource Type | Article |
| Subject | Oncology Cancer Research |